Bath & Body Works, Inc. (NYSE:BBWI) Shares Sold by Assenagon Asset Management S.A.

Assenagon Asset Management S.A. lowered its holdings in Bath & Body Works, Inc. (NYSE:BBWIFree Report) by 96.2% in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 44,121 shares of the company’s stock after selling 1,123,433 shares during the period. Assenagon Asset Management S.A.’s holdings in Bath & Body Works were worth $1,711,000 at the end of the most recent reporting period.

Several other large investors have also recently added to or reduced their stakes in the business. True Wealth Design LLC increased its stake in shares of Bath & Body Works by 5,270.0% during the third quarter. True Wealth Design LLC now owns 1,074 shares of the company’s stock worth $34,000 after buying an additional 1,054 shares during the period. Livforsakringsbolaget Skandia Omsesidigt increased its position in shares of Bath & Body Works by 300.0% in the 3rd quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 1,200 shares of the company’s stock valued at $38,000 after purchasing an additional 900 shares during the last quarter. Wilmington Savings Fund Society FSB acquired a new stake in shares of Bath & Body Works in the 3rd quarter valued at $39,000. TD Private Client Wealth LLC lifted its position in shares of Bath & Body Works by 24.2% during the 3rd quarter. TD Private Client Wealth LLC now owns 1,697 shares of the company’s stock worth $54,000 after purchasing an additional 331 shares during the last quarter. Finally, Meeder Asset Management Inc. grew its stake in shares of Bath & Body Works by 480.3% during the third quarter. Meeder Asset Management Inc. now owns 1,735 shares of the company’s stock worth $55,000 after purchasing an additional 1,436 shares in the last quarter. 95.14% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several brokerages have recently weighed in on BBWI. TD Cowen raised their target price on Bath & Body Works from $42.00 to $48.00 and gave the stock a “buy” rating in a research report on Thursday, December 12th. Morgan Stanley reduced their price objective on shares of Bath & Body Works from $51.00 to $48.00 and set an “overweight” rating for the company in a research report on Thursday, November 21st. Barclays lifted their price target on shares of Bath & Body Works from $28.00 to $34.00 and gave the stock an “underweight” rating in a research note on Tuesday, November 26th. Piper Sandler upped their price objective on shares of Bath & Body Works from $36.00 to $39.00 and gave the company a “neutral” rating in a research note on Monday, January 6th. Finally, Argus reaffirmed a “hold” rating on shares of Bath & Body Works in a report on Friday, January 10th. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating and ten have issued a buy rating to the company’s stock. According to data from MarketBeat, Bath & Body Works currently has a consensus rating of “Moderate Buy” and a consensus target price of $43.06.

Get Our Latest Report on BBWI

Bath & Body Works Trading Down 0.6 %

Shares of BBWI stock opened at $37.27 on Friday. Bath & Body Works, Inc. has a twelve month low of $26.20 and a twelve month high of $52.99. The company has a market capitalization of $8.07 billion, a PE ratio of 9.09, a price-to-earnings-growth ratio of 1.01 and a beta of 1.82. The firm has a fifty day simple moving average of $36.76 and a 200-day simple moving average of $33.66.

Bath & Body Works (NYSE:BBWIGet Free Report) last issued its quarterly earnings results on Monday, November 25th. The company reported $0.49 EPS for the quarter, beating analysts’ consensus estimates of $0.46 by $0.03. Bath & Body Works had a negative return on equity of 44.03% and a net margin of 12.43%. The firm had revenue of $1.61 billion during the quarter, compared to the consensus estimate of $1.58 billion. During the same quarter in the prior year, the business posted $0.48 earnings per share. Bath & Body Works’s revenue for the quarter was up 3.1% on a year-over-year basis. Equities research analysts predict that Bath & Body Works, Inc. will post 3.26 EPS for the current year.

Bath & Body Works Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, December 6th. Investors of record on Friday, November 22nd were issued a $0.20 dividend. This represents a $0.80 annualized dividend and a dividend yield of 2.15%. The ex-dividend date was Friday, November 22nd. Bath & Body Works’s dividend payout ratio (DPR) is 19.51%.

About Bath & Body Works

(Free Report)

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.

Featured Stories

Institutional Ownership by Quarter for Bath & Body Works (NYSE:BBWI)

Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.